Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device
Completed
Conditions studied: Age-related Macular Degeneration (AMD)
In brief
The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.
Key facts
- Study ID
- NCT02445313
- Run by
- Doheny Image Reading Center
- People needed
- 100
- Starts
- 2015-06-01
- Expected to finish
- 2019-02-12
- Last updated by the study team
- 2019-02-15
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Normal, healthy participants and patients with AMD
You may not qualify if…
- Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging
- Participants who are unable to maintain retinal fixation on a specified target
- Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place
- Patients with media opacity which preclude high quality imaging will be excluded.
- Exclusion criteria include vulnerable patients; patients under 18, pregnant, economically and educationally disadvantaged, decision impaired, or homeless people. We exclude pregnant women because pregnancy often can alter eye anatomy.
Where it is running
- Doheny Eye Centers UCLA — Pasadena, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.